RILYT vs TECH · rev $838.6M vs P/E 65, rev $1.22B
B. Riley Financial Inc. 6.00% Senior Notes Due 2028 (RILYT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
B. Riley Financial Inc. 6.00% Senior Notes Due 2028 (RILYT) common stock listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RILYT revenue for 2024-12-31 was $838.6M. Net income was -$774.9M. Revenue was down 42.8% from 2023-12-31 to 2024-12-31. RILYT currently screens at market cap $1.95B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RILYT currently screens at market cap $1.95B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RILYT and TECH stock pages for the full models.
Not investment advice.